Introduction
Esolina DSR Capsule by Astemax Biotech features esomeprazole enteric-coated pellets combined with domperidone sustained-release technology, providing comprehensive 24-hour relief from GERD and acid-related disorders. This advanced dual formula ensures protected acid suppression and enhanced gastric motility for optimal digestive health.
Formula Highlights
Esolina DSR contains esomeprazole 40 mg (enteric-coated) to block stomach acid production and domperidone 30 mg (sustained-release) to promote stomach emptying. The enteric coating shields esomeprazole from gastric acid, enabling precise intestinal release, while domperidone maintains steady action throughout the day.
Key Advantages
-
Rapidly relieves heartburn, regurgitation, bloating, and nausea associated with GERD and ulcers.
-
Prevents esophageal damage through potent proton pump inhibition and improved motility.
-
Supports once-daily dosing for high patient compliance and sustained symptom control.
Production Standards
Crafted in Astemax Biotech’s WHO-GMP certified facilities, Esolina DSR delivers consistent purity, stability, and bioavailability. Ethical marketing underscores proven clinical benefits for reliable physician recommendations.
Therapeutic Action
Esomeprazole inhibits the gastric proton pump to reduce acid by up to 95%, while domperidone acts as a prokinetic to accelerate gastric transit. The enteric-coated and sustained-release design maximizes efficacy with minimal side effects.
Administration Tips
Take one capsule daily before breakfast, swallowed whole with water. Consult doctors for prolonged use, pregnancy, or cardiac conditions. Store in cool, dry conditions below 30°C
